HEALTH
From Times Staff and Wire Reports
Pfizer to Spend $1 Billion on Drug Research: Pfizer Inc. said it will spend more than $1 billion in 1993 on research aimed at new drugs. The New York company said it already has four drugs in clinical research that have shown promising results. The four are tenidap, a prototype for a new class of drugs to treat arthritis; dofetilide, to treat heart rhythm disorders; zamifenacin, to treat irritable bowel syndrome; and CP-88,059, a new antipsychotic agent.
